In this episode of Meet the Greek, Dr. Petros Grivas and Dr. David Zhen discuss the latest advancements in gastrointestinal ...

Sabah Öney, President and Chief Executive Officer of Dispatch Bio joins Fred Hutch Board of Directors, bringing expertise in biotechnology leadership and innovation.

CAR T-cell therapy, which transforms patients’ own immune cells into cancer-fighting warriors, has revolutionized how physicians treat cancer, especially blood cancers. “These patients can be cured ...

Viral immunologist Paul Thomas, PhD, is working to turn the “incredible potential” of the immune system into real-life diagnostic and therapeutic applications that will improve vaccination strategies ...

In this conversation, Petros Grivas, MD, PhD, discusses his new podcast aimed at exploring the latest developments in cancer care and research. He emphasizes the importance of learning from colleagues ...

Some patients become advocates because everything went right: the diagnosis was made early, the surgery went well, the cancer-driving mutation was found and communicated to other family members, ...

A blackboard hangs in the office of bone marrow transplant pioneer Rainer Storb, MD, in Fred Hutch Cancer Center’s South Lake Union campus in Seattle. That board is where many of the lifesaving ...

Fred Hutch researchers invent a CRISPR screening method to understand RNA-binding proteins often mutated in cancer and other diseases In biology’s standard tale of two acids — deoxyribonucleic (DNA) ...

A study published in Nature finds that some cancer patients can make their “own companion drug,” suggesting a potential template for future treatments SEATTLE — July 23, 2025 — A landmark study has ...

Stuart and Molly Sloan add to their 2022 transformational gift to boost their impact on research and care SEATTLE – July 22, 2025 – A Fred Hutch Cancer Center outpatient complex serving more than ...

Study aims to understand the effectiveness and use of multi-cancer detection blood tests SEATTLE – July 15, 2025 – Fred Hutch Cancer Center is leading the newly launched Vanguard Study, a national ...

During his 36-year career at Fred Hutch Cancer Center, Michael Emerman, PhD, made fundamental discoveries about HIV, the retrovirus that causes AIDS. He and Fred Hutch evolutionary biologist Harmit ...